Interstitial Lung Disease Associated with Lung Cancer: A Case-Control Study.
interstitial lung disease
lung cancer
outcomes
prognosis
retrospective
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
05 Mar 2020
05 Mar 2020
Historique:
received:
10
02
2020
revised:
24
02
2020
accepted:
02
03
2020
entrez:
11
3
2020
pubmed:
11
3
2020
medline:
11
3
2020
Statut:
epublish
Résumé
Interstitial lung disease (ILD) seems to be associated with an increased risk of lung cancer (LC) and to have a poorer prognosis than LC without ILD. The frequency of ILD in an LC cohort and its prognosis implication need to be better elucidated. This retrospective, observational, cohort study evaluated the frequency of ILD among LC patients (LC-ILD) diagnosed over a 2-year period. LC-ILD patients' characteristics were compared to those with LC without ILD (LC-noILD). Lastly, we conducted a case-control study within this cohort, matching three LC-noILDs to each LC-ILD patient, to evaluate the ILD impact on LC patients' prognoses. Among 906 LC patients, 49 (5.4%) also had ILD. Comparing LC-ILD to LC-noILD patients, respectively, more were men (85.7% vs. 66.2%;
Identifiants
pubmed: 32150840
pii: jcm9030700
doi: 10.3390/jcm9030700
pmc: PMC7141363
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Ann Oncol. 2012 Oct;23 Suppl 7:vii56-64
pubmed: 22997455
Eur J Cardiothorac Surg. 2015 Jan;47(1):135-42
pubmed: 24699203
Respir Med. 2014 Mar;108(3):524-30
pubmed: 24462477
Radiology. 2008 Apr;247(1):251-9
pubmed: 18270375
Am J Respir Crit Care Med. 2000 Jan;161(1):5-8
pubmed: 10619790
J Thorac Dis. 2018 Jun;10(6):3829-3844
pubmed: 30069384
Oncol Lett. 2012 Sep;4(3):477-482
pubmed: 23741246
Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68
pubmed: 30168753
Anticancer Res. 2012 Dec;32(12):5475-80
pubmed: 23225454
J Thorac Oncol. 2009 Sep;4(9):1049-59
pubmed: 19652623
Thorax. 2010 Jan;65(1):70-6
pubmed: 19996344
Cancer Immunol Immunother. 2015 Oct;64(10):1261-70
pubmed: 26122358
Am J Respir Cell Mol Biol. 2008 Jul;39(1):45-52
pubmed: 18276795
Respir Med. 2007 Dec;101(12):2534-40
pubmed: 17870458
Chest. 1995 Nov;108(5):1272-7
pubmed: 7587428
J Thorac Cardiovasc Surg. 2015 Jan;149(1):64-9, 70.e1-2
pubmed: 25439777
Thorax. 1980 Jul;35(7):496-9
pubmed: 7434310
Eur Respir J. 2001 Dec;18(6):1059-68
pubmed: 11829087
J Thorac Cardiovasc Surg. 2003 Jun;125(6):1321-7
pubmed: 12830051
Ann Oncol. 2010 May;21 Suppl 5:v120-5
pubmed: 20555060
Cancers (Basel). 2018 Aug 02;10(8):
pubmed: 30072613
Chest. 2002 Apr;121(4):1278-89
pubmed: 11948064
Lung. 2015 Feb;193(1):71-7
pubmed: 25381634
J Cancer Res Clin Oncol. 2016 Aug;142(8):1855-65
pubmed: 27350261
Ann Thorac Surg. 2003 Nov;76(5):1674-8; discussion 1679
pubmed: 14602310
Interact Cardiovasc Thorac Surg. 2018 Apr 1;26(4):638-643
pubmed: 29272403
Lancet. 2017 May 13;389(10082):1941-1952
pubmed: 28365056
Ann Thorac Surg. 2011 Nov;92(5):1812-7
pubmed: 21944440
Eur J Radiol. 2015 May;84(5):998-1004
pubmed: 25726730
Pulm Med. 2011;2011:290132
pubmed: 22191026
Eur J Cardiothorac Surg. 2013 Jan;43(1):e17-23
pubmed: 23129356
Thorac Cancer. 2018 Jul;9(7):847-855
pubmed: 29782069
Pathol Int. 1999 Dec;49(12):1060-6
pubmed: 10632926
AJR Am J Roentgenol. 2016 Mar;206(3):487-94
pubmed: 26700157
Int J Clin Oncol. 2014 Apr;19(2):266-73
pubmed: 23660786
Eur Respir J. 2010 Mar;35(3):496-504
pubmed: 20190329
J Thorac Oncol. 2014 Aug;9(8):1162-70
pubmed: 25157769
Ann Oncol. 2010 May;21 Suppl 5:v103-15
pubmed: 20555058
Respiration. 2013;85(4):326-31
pubmed: 23171837
Chest. 2015 Jan;147(1):157-164
pubmed: 25166895
Eur Respir J. 2001 Jun;17(6):1216-9
pubmed: 11491167